Advanced chronic kidney disease: a strong risk factor for Clostridium difficile infection
1
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
Background/Aims: It has been suggested that chronic kidney disease (CKD) is a risk factor for Clostridium difficile infection (CDI) and is associated with increased mortality among patients infected with C. difficile. However, recent studies of the clinical impact of CKD on CDI in Asians are still insufficient. We sought to determine the relationship between CKD and CDI in a Korean population. Methods: This was a single-center, retrospective case-control study. In total, 171 patients with CDI were included as cases and 342 age- and gender-matched patients without CDI were used as controls. We compared the prevalence of CKD in the study sample and identified independent risk factors that could predict the development or prognosis of CDI. Results: Independent risk factors for CDI included stage IV to V CKD not requiring dialysis (odds ratio [OR], 2.90) and end-stage renal disease requiring dialysis (OR, 3.34). Patients with more advanced CKD (estimated glomerular filtration rate < 30) and CDI showed higher in-hospital mortality and poorer responses to the initial metronidazole therapy. Conclusions: More advanced CKD is an independent risk factor for CDI and is associated with higher in-hospital mortality and poor treatment responses in CDI patients. Thus, in CKD patients, careful attention should be paid to the occurrence of CDI and its management to improve the outcome of CDI.
Abstract
Background/Aims: It has been suggested that chronic kidney disease (CKD) is a risk factor for Clostridium difficile infection (CDI) and is associated with increased mortality among patients infected with C. difficile. However, recent studies of the clinical impact of CKD on CDI in Asians are still insufficient. We sought to determine the relationship between CKD and CDI in a Korean population. Methods: This was a single-center, retrospective case-control study. In total, 171 patients with CDI were included as cases and 342 age- and gender-matched patients without CDI were used as controls. We compared the prevalence of CKD in the study sample and identified independent risk factors that could predict the development or prognosis of CDI. Results: Independent risk factors for CDI included stage IV to V CKD not requiring dialysis (odds ratio [OR], 2.90) and end-stage renal disease requiring dialysis (OR, 3.34). Patients with more advanced CKD (estimated glomerular filtration rate < 30) and CDI showed higher in-hospital mortality and poorer responses to the initial metronidazole therapy. Conclusions: More advanced CKD is an independent risk factor for CDI and is associated with higher in-hospital mortality and poor treatment responses in CDI patients. Thus, in CKD patients, careful attention should be paid to the occurrence of CDI and its management to improve the outcome of CDI.
참고문헌 (21)
- Howell MD, "Iatrogenic gastric acid suppression and the risk of nosocomial Clostridium difficile infection", Arch Intern Med, 170, pp.784~790 (2010)
- Bignardi GE, "Risk factors for Clostridium difficile infection", J Hosp Infect, 40, pp.1~15 (1998)
- Anand A, "Clostridium difficile infection associated with antineoplastic chemotherapy: a review", Clin Infect Dis, 17, pp.109~113 (1993)
- McFarland LV, "Risk factors for Clostridium difficile carriage and C. difficile-associated diarrhea in a cohort of hospitalized patients", J Infect Dis, 162, pp.678~684 (1990)
- McFarland LV, "Nosocomial acquisition of Clostridium difficile infection", N Engl J Med, 320, pp.204~210 (1989)
- Peniche AG, "Recent insights into Clostridium difficile pathogenesis", Curr Opin Infect Dis, 26, pp.447~453 (2013)
- Loo VG, "A predominantly clonal multi-institutional outbreak of Clostridium difficile-associated diarrhea with high morbidity and mortality", N Engl J Med, 353, pp.2442~2449 (2005)
- Pepin J, "Mortality attributable to nosocomial Clostridium difficile-associated disease during an epidemic caused by a hypervirulent strain in Quebec", CMAJ, 173, pp.1037~1042 (2005)
- Kuijper EJ, "Clostridium difficile:changing epidemiology and new treatment options", Curr Opin Infect Dis, 20, pp.376~383 (2007)
- Eddi R, "Chronic kidney disease as a risk factor for Clostridium difficile infection", Nephrology, 15, pp.471~475 (2010)
- Pardi DS, "Recurrent Clostridium difficile infection: an immunodeficiency state?", Clin Gastroenterol Hepatol, 5, pp.672~673 (2007)
- Aronsson B, "Clostridium difficile-associated diarrhoea in uremic patients", Eur J Clin Microbiol, 6, pp.352~356 (1987)
- McConnell JB, "Gastric function in chronic renal failure: effects of maintenance haemodialysis", Lancet, 2, pp.1121~1123 (1975)
- Hida M, "Inhibition of the accumulation of uremic toxins in the blood and their precursors in the feces after oral administration of Lebenin, a lactic acid bacteria preparation, to uremic patients undergoing hemodialysis", Nephron, 74, pp.349~355 (1996)
- Keddis MT, "Clostridium difficile infection in patients with chronic kidney disease", Mayo Clin Proc, 87, pp.1046~1053 (2012)
- Yousuf K, "Clostridium difficile-associated diarrhea and chronic renal insufficiency", South Med J, 95, pp.681~683 (2002)
- Mullane KM, "Renal impairment and clinical outcomes of Clostridium difficile in-fection in two randomized trials", Am J Nephrol, 38, pp.1~11 (2013)
- Anders HJ, "The intestinal microbiota, a leaky gut, and abnormal immunity in kidney disease", Kidney Int, 83, pp.1010~1016 (2013)
- Betjes MG, "Immune cell dysfunction and inflammation in end-stage renal disease", Nat Rev Nephrol, 9, pp.255~265 (2013)
- Monaghan T, "Recent advances in Clostridium difficile-associated disease", Gut, 57, pp.850~860 (2008)
- Cohen SH, "Clinical practice guidelines for Clostridium difficile infection in adults:2010 update by the society for healthcare epidemiology of America (SHEA) and the infectious diseases society of America (IDSA)", Infect Control Hosp Epidemiol, 31, pp.431~455 (2010)